Home > Qtrly Results > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]

TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Revenues ₹2,809 Cr ₹2,889 Cr ₹2,859 Cr ₹2,745 Cr ₹2,732 Cr ₹2,660 Cr ₹2,591 Cr ₹2,491 Cr
Expenses ₹1,895 Cr ₹1,950 Cr ₹1,955 Cr ₹1,862 Cr ₹1,863 Cr ₹1,835 Cr ₹1,800 Cr ₹1,764 Cr
Operating Income ₹914 Cr ₹939 Cr ₹904 Cr ₹883 Cr ₹869 Cr ₹825 Cr ₹791 Cr ₹727 Cr
Other Income ₹33 Cr ₹-16 Cr ₹24 Cr ₹31 Cr ₹-33 Cr ₹26 Cr ₹34 Cr ₹9 Cr
Interest ₹57 Cr ₹64 Cr ₹75 Cr ₹80 Cr ₹80 Cr ₹91 Cr ₹103 Cr ₹107 Cr
Depreciation ₹199 Cr ₹198 Cr ₹197 Cr ₹203 Cr ₹213 Cr ₹201 Cr ₹191 Cr ₹196 Cr
Profit Before Tax ₹691 Cr ₹661 Cr ₹656 Cr ₹631 Cr ₹631 Cr ₹559 Cr ₹531 Cr ₹433 Cr
Profit After Tax ₹503 Cr ₹453 Cr ₹457 Cr ₹449 Cr ₹443 Cr ₹386 Cr ₹378 Cr ₹287 Cr
EPS ₹14.86 ₹13.38 ₹13.50 ₹13.27 ₹13.09 ₹11.40 ₹11.17 ₹8.48
Industry Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS 0.1% 7.2% 25.7%
SUN PHARMACEUTICAL INDUSTRIES -3% 5.6% 9.3%
DIVIS LABORATORIES 1% 2.7% 70.3%
CIPLA -2.7% 0.4% -0.4%
DR REDDYS LABORATORIES -3.1% -0.2% -6.2%
MANKIND PHARMA 2% 7.1% 8.8%
ZYDUS LIFESCIENCES -3% 0.1% -9.3%
LUPIN -4.6% 6.1% 28%
AUROBINDO PHARMA -2.8% 5.9% 13.4%

TORRENT PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-2.77 %

Y-o-Y

2.82 %

Quarters Revenues % Change
Dec2024 ₹2,809 Cr
-2.77
Sep2024 ₹2,889 Cr
1.05
Jun2024 ₹2,859 Cr
4.15
Mar2024 ₹2,745 Cr
0.48
Dec2023 ₹2,732 Cr
2.71
Sep2023 ₹2,660 Cr
2.66
Jun2023 ₹2,591 Cr
4.01
Mar2023 ₹2,491 Cr -

TORRENT PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-2.66 %

Y-o-Y

5.18 %

Quarters Operating Profit % Change
Dec2024 ₹914 Cr
-2.66
Sep2024 ₹939 Cr
3.87
Jun2024 ₹904 Cr
2.38
Mar2024 ₹883 Cr
1.61
Dec2023 ₹869 Cr
5.33
Sep2023 ₹825 Cr
4.30
Jun2023 ₹791 Cr
8.80
Mar2023 ₹727 Cr -
Operating Margins
Q-o-Q

0.12 %

Y-o-Y

2.29 %

Quarters Operating Margin% % Change
Dec2024 32.54%
0.12
Sep2024 32.5%
2.78
Jun2024 31.62%
-1.71
Mar2024 32.17%
1.13
Dec2023 31.81%
2.55
Sep2023 31.02%
1.60
Jun2023 30.53%
4.59
Mar2023 29.19% -

TORRENT PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

11.04 %

Y-o-Y

13.54 %

Quarters Profit After Tax % Change
Dec2024 ₹503 Cr
11.04
Sep2024 ₹453 Cr
-0.88
Jun2024 ₹457 Cr
1.78
Mar2024 ₹449 Cr
1.35
Dec2023 ₹443 Cr
14.77
Sep2023 ₹386 Cr
2.12
Jun2023 ₹378 Cr
31.71
Mar2023 ₹287 Cr -
PAT Margins
Q-o-Q

14.22 %

Y-o-Y

10.42 %

Quarters PAT Margin(%) % Change
Dec2024 17.91 %
14.22
Sep2024 15.68 %
-1.88
Jun2024 15.98 %
-2.32
Mar2024 16.36 %
0.86
Dec2023 16.22 %
11.78
Sep2023 14.51 %
-0.55
Jun2023 14.59 %
26.65
Mar2023 11.52 % -

TORRENT PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

11.06 %

Y-o-Y

13.52 %

Quarters EPS % Change
Dec2024 ₹14.86
11.06
Sep2024 ₹13.38
-0.89
Jun2024 ₹13.5
1.73
Mar2024 ₹13.27
1.38
Dec2023 ₹13.09
14.82
Sep2023 ₹11.4
2.06
Jun2023 ₹11.17
31.72
Mar2023 ₹8.48 -

You may also like the below Video Courses